Trial Profile
Two-way crossover comparison of tofogliflozin and canagliflozin using continuous glucose monitoring.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2018
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 29 May 2018 Status changed from recruiting to completed.
- 29 Nov 2016 New trial record